• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用微载体技术“从安瓿瓶到500升发酵罐”生产奥耶斯基疫苗

Production of Aujeszky vaccine by the microcarrier technology "from the ampoule to the 500 litre fermentor".

作者信息

Baijot B, Duchene M, Stephenne J

出版信息

Dev Biol Stand. 1987;66:523-30.

PMID:2438178
Abstract

A process for the production of Aujeszky vaccine on microcarrier cultures in large fermentors is described. The NLST cells are routinely produced in fermentors of 150 litres; cell density reaches 0.7-0.8 10(6)/ml. The authors describe the method used to obtain those results. The different parameters used in fermentors are discussed and especially pO2 regulation. A study of subculturing method is being carried out to reach a volume of 500 litres. The comparison between stationary culture and microcarrier cultures shows the advantages of such a technique for the viral antigen produced versus infective and the increase of the bulk capacity. This experience also shows that specific development is required for each cell line.

摘要

描述了一种在大型发酵罐的微载体培养物上生产奥耶斯基疫苗的方法。NLST细胞通常在150升的发酵罐中生产;细胞密度达到0.7 - 0.8×10⁶/ml。作者描述了用于获得这些结果的方法。讨论了发酵罐中使用的不同参数,特别是pO₂调节。正在进行传代培养方法的研究以达到500升的体积。静态培养和微载体培养之间的比较显示了这种技术相对于感染性产生的病毒抗原的优势以及批量生产能力的提高。该经验还表明每个细胞系都需要特定的开发。

相似文献

1
Production of Aujeszky vaccine by the microcarrier technology "from the ampoule to the 500 litre fermentor".采用微载体技术“从安瓿瓶到500升发酵罐”生产奥耶斯基疫苗
Dev Biol Stand. 1987;66:523-30.
2
[Replication of the Aujeszky virus in vaccinated swine following experimental infection with large and medium amounts of virus].
Zentralbl Veterinarmed B. 1982 Feb;29(1):24-30.
3
[Pseudosuspended cultured cells for obtaining influenza A and B viral antigens].用于获取甲型和乙型流感病毒抗原的伪悬浮培养细胞
Vopr Virusol. 1994 Nov-Dec;39(6):274-6.
4
[Immunohistologic antigen demonstration and virus isolation in cell cultures in Aujeszky disease].[奥耶斯基病(伪狂犬病)的免疫组织学抗原显示及细胞培养中的病毒分离]
Berl Munch Tierarztl Wochenschr. 1981 Apr 1;94(7):128-30.
5
[Certain properties of the Aujeszky live vaccine "Dessau" with special reference to laboratory diagnostic aspects].[奥耶斯基“德绍”活疫苗的某些特性,特别涉及实验室诊断方面]
Arch Exp Veterinarmed. 1980;34(1):79-86.
6
Evaluation of a microcarrier process for large-scale cultivation of attenuated hepatitis A.
Cytotechnology. 1992;9(1-3):173-87. doi: 10.1007/BF02521745.
7
[Comparative investigations of practice-oriented methods for the detection of viruses in food with Aujeszky infection in swine as an example].
Zentralbl Veterinarmed B. 1997 Nov;44(9):565-76.
8
[Results of Aujeszky disease control using marker vaccines].[使用标记疫苗控制奥耶斯基病的结果]
Tijdschr Diergeneeskd. 1995 Sep 1;120(17):502-4.
9
[Inoculation of swine with inactivated Aujeszky vaccine: reduction of the inoculation dose, a cutaneous allergy test and the effect of vaccination on viremia].
Dtsch Tierarztl Wochenschr. 1979 Nov 5;86(5):438-40.
10
[Vaccination using the inactivated Aujeszky disease virus (ADV) during the incubation period of ADV infection. Attempt at provoking infection].
Dtsch Tierarztl Wochenschr. 1978 Jul 5;85(7):285-8.

引用本文的文献

1
Production of high titre disabled infectious single cycle (DISC) HSV from a microcarrier culture.从微载体培养物中生产高滴度失活传染性单循环(DISC)HSV。
Cytotechnology. 1999 Jul;30(1-3):203-10. doi: 10.1023/A:1008005200711.
2
BHK 21 C13 cells for Aujeszky's disease virus production using the multiple harvest process.使用多收获工艺生产 Aujeszky 氏病病毒的 BHK 21 C13 细胞。
Cytotechnology. 2004 Jul;45(3):101-6. doi: 10.1007/s10616-004-2551-z.
3
Aujeszky's disease virus production in disposable bioreactor.
J Biosci. 2006 Sep;31(3):363-8. doi: 10.1007/BF02704109.
4
High titre Hog Cholera virus production on Cytodex 3 microcarrier cultures.在Cytodex 3微载体培养物上生产高滴度猪霍乱病毒。
Arch Virol. 1989;105(1-2):113-8. doi: 10.1007/BF01311121.
5
Evaluation of a microcarrier process for large-scale cultivation of attenuated hepatitis A.
Cytotechnology. 1992;9(1-3):173-87. doi: 10.1007/BF02521745.